⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16455 | 0.84 | LMNA (0.41) | — | |
| Hydrochloric Acid SCHEMBL28869556 | 0.79 | TSHR (0.37) | — | |
| Guanidine SCHEMBL28078381 | 0.77 | TSHR (0.35) | — | |
| SCHEMBL6013580 | 0.74 | — | — | |
| SCHEMBL28227742 | 0.72 | MEN1 (0.32) | — | |
| SCHEMBL8781705 | 0.72 | MEN1 (0.32) | — | |
| Biguanide SCHEMBL28138888 | 0.70 | MEN1 (0.31) | — | |
| SCHEMBL7253508 | 0.69 | — | — | |
| SCHEMBL161898 | 0.69 | — | — | |
| SCHEMBL1023587 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130005803-A1 | USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SKIN DISORDERS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2013-01-03 | — | — | US | disclosed |
| EP-2512465-A1 | USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SKIN DISORDERS | Galderma Research & Development (FR) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011073248-A1 | USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SKIN DISORDERS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2011-06-23 | — | — | WO | disclosed |